| IRS1 |
IRS1: Insulin receptor substrate 1 |
PRKCE |
PRKCE, PKCE: Protein kinase C epsilon type |
21.130 |
Evidence |
|
| IRS1 |
IRS1: Insulin receptor substrate 1 |
TEC |
TEC, PSCTK4: Tyrosine-protein kinase Tec |
21.130 |
Evidence |
|
| PRKR |
EIF2AK2, PKR, PRKR: Interferon-induced, double-stranded RNA-activated protein ki |
STAT5B |
STAT5B: Signal transducer and activator of transcription 5B |
21.130 |
Evidence |
|
| EPOR |
EPOR: Erythropoietin receptor precursor |
KDR |
KDR, FLK1: Vascular endothelial growth factor receptor 2 precursor |
21.130 |
Evidence |
|
| CDH2 |
CDH2, CDHN, NCAD: Cadherin-2 precursor |
GRIA1 |
GRIA1, GLUH1, GLUR1: Glutamate receptor 1 precursor |
21.130 |
Evidence |
|
| RPA2 |
RPA2, REPA2, RPA32, RPA34: Replication protein A 32 kDa subunit |
BRCA2 |
BRCA2, FACD, FANCD1: Breast cancer type 2 susceptibility protein |
21.130 |
Evidence |
|
| PABPC1 |
PABPC1, PAB1, PABP1, PABPC2: Polyadenylate-binding protein 1 |
MECP2 |
MECP2: Methyl-CpG-binding protein 2 |
21.130 |
Evidence |
|
| MET |
MET: Hepatocyte growth factor receptor precursor |
KDR |
KDR, FLK1: Vascular endothelial growth factor receptor 2 precursor |
21.130 |
Evidence |
|
| INSR |
INSR: Insulin receptor precursor |
PRLR |
PRLR: Prolactin receptor precursor |
21.130 |
Evidence |
|
| SERPING1 |
SERPING1, C1IN, C1NH: Plasma protease C1 inhibitor precursor |
THBD |
THBD, THRM: Thrombomodulin precursor |
21.130 |
Evidence |
|
| ERBB2 |
ERBB2, HER2, NEU, NGL: Receptor tyrosine-protein kinase erbB-2 precursor |
AREG |
AREG, SDGF: Amphiregulin precursor |
21.130 |
Evidence |
|
| ERBB2 |
ERBB2, HER2, NEU, NGL: Receptor tyrosine-protein kinase erbB-2 precursor |
CEACAM1 |
CEACAM1, BGP, BGP1: Carcinoembryonic antigen-related cell adhesion molecule 1 pr |
21.130 |
Evidence |
|
| ANXA1 |
ANXA1, ANX1, LPC1: Annexin A1 |
ERBB2 |
ERBB2, HER2, NEU, NGL: Receptor tyrosine-protein kinase erbB-2 precursor |
21.130 |
Evidence |
|
| FGA |
IPI00021885 |
SERPING1 |
SERPING1, C1IN, C1NH: Plasma protease C1 inhibitor precursor |
21.130 |
Evidence |
|
| PLG |
PLG: Plasminogen precursor |
PRSS22 |
PRSS22, BSSP4, SP001LA, PRSS26, UNQ302/PRO343: Brain-specific serine protease 4 |
21.130 |
Evidence |
|
| STAM2 |
STAM2: Signal transducing adapter molecule 2 |
IRS2 |
IRS2: Insulin receptor substrate 2 |
21.130 |
Evidence |
|
| STAM2 |
STAM2: Signal transducing adapter molecule 2 |
INSL3 |
JAK3: Tyrosine-protein kinase JAK3 |
21.130 |
Evidence |
|
| STAM2 |
STAM2: Signal transducing adapter molecule 2 |
IRS1 |
IRS1: Insulin receptor substrate 1 |
21.130 |
Evidence |
|
| TOM1L1 |
TOM1L1, SRCASM: TOM1-like protein 1 |
STAM2 |
STAM2: Signal transducing adapter molecule 2 |
21.130 |
Evidence |
|
| WASPIP |
IPI00552369 |
SRC |
SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src |
21.130 |
Evidence |
|
| EIF4G3 |
EIF4G3: Eukaryotic translation initiation factor 4 gamma 3 |
EIF4G1 |
EIF4G1, EIF4F, EIF4G, EIF4GI: Eukaryotic translation initiation factor 4 gamma 1 |
21.130 |
Evidence |
|
| PLD2 |
PLD2: Phospholipase D2 |
PLCG1 |
PLCG1, PLC1: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-1 |
21.130 |
Evidence |
|
| SOCS3 |
SOCS3, CIS3, SSI3: Suppressor of cytokine signaling 3 |
CRKL |
CRKL: Crk-like protein |
21.130 |
Evidence |
|
| SOCS3 |
SOCS3, CIS3, SSI3: Suppressor of cytokine signaling 3 |
STAM2 |
STAM2: Signal transducing adapter molecule 2 |
21.130 |
Evidence |
|
| CHRNA4 |
CHRNA4, NACRA4: Neuronal acetylcholine receptor subunit alpha-4 precursor |
CHRNA2 |
CHRNA2: Neuronal acetylcholine receptor subunit alpha-2 precursor |
21.130 |
Evidence |
|